Bone Morphogenic Protein Signaling and Melanoma.
Opinion Statement: Malignant melanoma is a deadly form of skin cancer caused by neoplastic transformation of melanocytic cells. Despite recent progress in melanoma therapy, by inhibition of activated oncogenes or immunotherapy, survival rate for metastatic melanoma patients remains low. The remarkab...
| Publicado en: | Current Treatment Options in Oncology Vol. 22; no. 6; pp. 1 - 13 |
|---|---|
| Autor principal: | |
| Formato: | review Journal Article |
| Publicado: |
Springer Nature
Jun2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |